Prescription Drug Histories among Drug Overdose Decedents in Delaware

References

• American Medical Association (AMA). (2016). Preventing opioid abuse: Be part of the solution. http://www.ama-assn.org/ama/pub/advocacy/topics/preventingopioid-abuse.page
   Google Scholar
• Anderson, T. L., Zhang, X., Martin, S. S., Fang, Y., & Li, J. (2019). Understanding differences in types of opioid prescriptions across time and space: A community-level analysis. Journal of Drug Issues, 49(2), 405–418. https://doi.org/10.1177/0022042618815687
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2018). Overdose Waves. https://www.cdc.gov/drugoverdose/data/analysis.html
   Google Scholar
• Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014). The changing face of heroin use in the United States: A retrospective analysis of the past 50 years. JAMA Psychiatry, 71(7), 821–826. https://doi.org/10.1001/jamapsychiatry.2014.366
   PubMed Web of Science ®Google Scholar
• Drug Enforcement Administration (DEA). (2017). National drug threat assessment, 2017. https://www.dea.gov/sites/default/files/2018-07/DIR-040-17_2017-NDTA.pdf
   Google Scholar
• Drug Enforcement Administration (DEA). (2015). DEA issues nationwide alert on fentanyl as threat to health and public safety. DEA Press Releases. https://www.dea.gov/press-releases/2015/03/18/dea-issues-nationwide-alert-fentanyl-threat-health-and-public-safety
   Google Scholar
• Dusetzina, S. B., Tyree, S., Meyer, A. M., Meyer, A., Green, L., & Carpenter, W. R. (2014). Linking data for health services research: A framework and instructional guide. AHRQ Publication No. 14-EHC033-EF. Agency for Healthcare Research and Quality.
   Google Scholar
• Fain, K. M., Castillo-Salgado, C., Dore, D. D., Segal, J. B., Zullo, A. R., & Alexander, G. C. (2017). Inappropriate fentanyl prescribing among nursing home residents in the United States. Journal of the American Medical Directors Association, 18(2), 138–144. https://doi.org/10.1016/j.jamda.2016.08.015
   PubMed Web of Science ®Google Scholar
• Fox, L. M., Hoffman, R. S., Vlahov, D., & Manini, A. F. (2018). Risk factors for severe respiratory depression from prescription opioid overdose. Addiction, 113(1), 59–66. https://doi.org/10.1111/add.13925
   PubMed Web of Science ®Google Scholar
• Friesen, K. J., Woelk, C., & Bugden, S. (2016). Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches. Canadian Medical Association Journal, 188(9), 648–653. https://doi.org/10.1503/cmaj.150961
   Web of Science ®Google Scholar
• Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018). Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science, 361(6408), eaau1184. https://doi.org/10.1126/science.aau1184
   PubMed Web of Science ®Google Scholar
• Jennings, W. G., Perez, N., Delcher, C., & Wang, Y. (2020). Opioid prescribing rates and criminal justice and health outcomes. SpringerBriefs in Criminology, Springer International Publishing.
   Google Scholar
• Knight, K., Kushel, M., Chang, J. S., Zamora, K., Ceasar, R., Hurstak, E., & Miaskowski, C. (2017). Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use Pergamon. Social Science & Medicine, 186, 87–95. https://doi.org/10.1016/j.socscimed.2017.05.043
   PubMed Web of Science ®Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559–574. https://doi.org/10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Levy, B., Paulozzi, L., Mack, K. A., & Jones, C. M. (2015). Trends in opioid analgesic–PRESCRIBING rates by specialty, US, 2007–2012. American Journal of Preventive Medicine, 49(3), 409–413. https://doi.org/10.1016/j.amepre.2015.02.020
   PubMed Web of Science ®Google Scholar
• Manchikanti, L., & Singh, A. (2008). Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician, 11(2 Suppl), S63–S88.
   PubMed Web of Science ®Google Scholar
• Muhuri, P. K., Gfroerer, J. C., Davies, M. C. (2013). Substance Abuse and Mental Health Services Administration. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. http://www.samhsa.gov/data/2k13/DataReview/DR006/nonmedical-pain-reliever-use-2013.pdf
   Google Scholar
• Nechuta, S. J., Tyndall, B. D., Mukhopadhyay, S., & McPheeters, M. L. (2018). Sociodemographic factors, prescription history and opioid overdose deaths: A statewide analysis using linked PDMP and mortality data. Drug and Alcohol Dependence, 190, 62–71. https://doi.org/10.1016/j.drugalcdep.2018.05.004
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA). (2018). Prescription opioids and heroin. NIDA. https://www.drugabuse.gov/publications/research-reports/relationship-between-prescription-drug-heroin-abuse/prescription-opioid-use-risk-factor-heroin-use
   Google Scholar
• Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011). Vital signs: Overdoses of prescription opioid pain relievers – United States, 1999–2008. Morbidity and Mortality Weekly Report, 60(43), 1487–1492.
   PubMedGoogle Scholar
• Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Medicine (Malden, Mass.), 12(5), 747–754. https://doi.org/10.1111/j.1526-4637.2011.01062.x
   PubMed Web of Science ®Google Scholar
• Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., Harvey, W., & Loring, L. D. (2012). A history of being prescribed controlled substances and risk of drug overdose death. Pain Medicine (Malden, Mass.), 13(1), 87–95. https://doi.org/10.1111/j.1526-4637.2011.01260.x
   PubMed Web of Science ®Google Scholar
• Peterson, A. B., Gladden, R. M., Delcher, C., Spies, E., Garcia-Williams, A., Wang, Y., Halpin, J., Zibbell, J., McCarty, C. L., DeFiore-Hyrmer, J., DiOrio, M., & Goldberger, B. A. (2016). Increases in fentanyl-related overdose deaths - Florida and Ohio, 2013-2015. MMWR. Morbidity and Mortality Weekly Report, 65(33), 844–849. https://doi.org/10.15585/mmwr.mm6533a3
   PubMed Web of Science ®Google Scholar
• Rollman, J. E., Heyward, J., Olson, L., Lurie, P., Sharfstein, J., & Alexander, G. C. (2019). Assessment of the FDA Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl products. JAMA, 321(7), 676–685. https://doi.org/10.1001/jama.2019.0235
   PubMed Web of Science ®Google Scholar
• Rosenberg, E. (2019, June 5). Maker of Addictive Fentanyl Spray agrees to pay $225 million in prescriptions- for-cash scheme. Washington Post. https://www.washingtonpost.com/health/2019/06/06/drug-maker-addictiv/
   Google Scholar
• Schepis, T. S., McCabe, V. V., Boyd, C. J., & McCabe, S. E. (2019). The epidemiology of prescription fentanyl misuse in the United States. Addictive Behaviors, 96, 89–93. https://doi.org/10.1016/j.addbeh.2019.04.022
   PubMed Web of Science ®Google Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427.
   Google Scholar
• Viviano, J. (2019, January 15). Hospital says doctor gave 27 patients potentially fatal doses of fentanyl. The Independent. https://www.indeonline.com/news/20190115/hospital-says-doctor-gave-27-patients-potentially-fatal-doses-of-fentanyl?template=ampart
   Google Scholar